A Drug & Medical Device Recall And/Or Safety Alert Has Been Issued: Zofran (ondansetron): Drug Safety Communication – Risk of Abnormal Heart Rhythms. According to the Food & Drug Administration FDA’s MedWatch:
Avoid use of ondansetron in patients with congenital long QT syndrome, and monitor those with electrolyte abnormalities, CHF, bradyarrhythmias, or those taking concomitant medications that prolong the QT interval.
For more information on the drug or medical device recall or safety alert, read the Food & Drug Administration’s FDA’s drug or medical device recall or safety alert: Zofran (ondansetron): Drug Safety Communication – Risk of Abnormal Heart Rhythms.
To report an adverse reaction, problem or other issue with a drug or medical device, submit a drug or medical device complaint to the government at fda.gov or MedWatch.
If you have thoughts on the drug or medical device recall or safety alert, share your drug or medical device recall or safety alert comments below.